What is Terumo Aortic?
Founded in 1921 and headquartered in Renfrewshire, United Kingdom, Terumo Aortic operates as a critical subsidiary within the broader medical device ecosystem. The company specializes in the design, development, and manufacturing of sophisticated solutions tailored for the treatment of aortic and peripheral vascular pathologies. With a century-long legacy of engineering excellence, the firm maintains a robust portfolio of surgical and endovascular products, serving as a primary partner for healthcare providers globally. Their market position is defined by a rigorous focus on patient outcomes and the integration of advanced materials science into life-saving vascular technologies.
How much funding has Terumo Aortic raised?
Terumo Aortic has raised a total of $45.7M across 1 funding round:
Other Financing Round
$45.7M
Other Financing Round (2018): $45.7M with participation from Terumo Corporation
Key Investors in Terumo Aortic
Terumo Corporation
A global leader in medical technology and healthcare solutions, Terumo Corporation focuses on the development of innovative products for cardiovascular, blood management, and general hospital systems.
What's next for Terumo Aortic?
Looking ahead, the infusion of capital is expected to accelerate the company's research and development pipeline, specifically targeting next-generation endovascular repair systems. As the medical device industry shifts toward minimally invasive procedures, Terumo Aortic is strategically positioned to capture additional market share by expanding its clinical trial initiatives and enhancing its manufacturing capabilities. The firm's trajectory suggests a continued emphasis on global scalability, with a focus on navigating the complex regulatory landscapes of international healthcare markets to ensure sustained long-term growth and technological leadership.
See full Terumo Aortic company page
